Source: Virtual Congress 2021 – Immunological and molecular characterisation of tuberculosis disease and infection



Rating:

Share or cite this content

Citations should be made in the following way:
K. Galkina (Moscow, Russian Federation), M. Sviridenko (Moscow, Russian Federation), E. Nosova (Moscow, Russian Federation), A. Khakhalina (Moscow, Russian Federation), A. Isakova (Moscow, Russian Federation), S. Safonova (Moscow, Russian Federation). Determination of the six polymorphisms in the NAT2 gene helps to predict isoniazid side effects.. 2476

Member's Comments

No comment yet.

Related content which might interest you: Predicting the efficiency of the treatment of drug-resistant tuberculosis depending on the polymorphism variation of glutathione-S-transferase genes Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Influence of allele variants of CYP2A6 and NAT2 genes on features of phenotype of tobacco smoker Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 NAT2 genotyping individualization of isoniazid treatment Source: Annual Congress 2010 - Scientific advances in tuberculosis Year: 2010 TNF-α promoter polymorphisms analysis in the susceptibility to beryllium-hypersensitivity Source: Eur Respir J 2003; 22: Suppl. 45, 186s Year: 2003 The influence of polymorphism of GSTT1 ,GSTM1, ACE genes on the development of BA in children Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009 Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003 N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Presence of Cox2 polymorphisms and susceptibility to sarcoidosis and its evolution Source: Eur Respir J 2007; 30: Suppl. 51, 113s Year: 2007 Relationship of interleukin 10 1082 G/A gene polymorphism with the duration of nephrotoxic onset due to anti tuberculosis drugs in multi drug resistant tuberculosis patients Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Analysis of association between the GSTT1 and GSTM1 genes polymorphism and asthma-associated traits (AAT) Source: Eur Respir J 2003; 22: Suppl. 45, 581s Year: 2003 The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006 Risk of antituberculosis drug (ATD)-induced hepatotoxicity and polymorphisms at the glutatione S-transferase (GST) loci (GSTM1 and GSTT1) Source: Eur Respir J 2006; 28: Suppl. 50, 342s Year: 2006 Genetic polymorphisms CYP1A1 m1, GSTM1, GSTT1 null and lung cancer susceptibility in a Brazilian population Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006 Genetic polymorphism of NAT-2 gene in adolescents with variable course of infiltrative tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007 Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma Source: Eur Respir J 2004; 24: Suppl. 48, 136s Year: 2004 Influence of polymorphic variants of DRD2 and SLC6A3 genes and their combinations on smoking habit in Polish population Source: Annual Congress 2008 - The biology of smoking and COPD Year: 2008 Associations between genetic polymorphisms and drug response phenotypes in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007 The role of GSTT1 and GSTM1 gene polymorphisms in bronchial asthma Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018 Genetic polymorphisms of k-ras gene in smoking related diseases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012